About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Teriparatide

Company: Columbia University
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: 6 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

6 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details

Recruiting NCT NCT04522622

Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease

Not yet reported Ditte Hansen 48 participants Est. completion 2027-09-01 4 sites Stand-alone

Chronic kidney disease Other conditions: Adynamic Bone Disease, Cardiac Disease
View official trial listing →
Recruiting NCT NCT05866029

Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

Not yet reported Peking Union Medical College Hospital 2478 participants Est. completion 2026-09-30 58 sites Stand-alone

Other conditions: Osteoporotic Fractures
View official trial listing →
Recruiting NCT NCT06164795

Sequential Therapies After Osteoanabolic Treatment

424 General Military Hospital 150 participants Est. completion 2027-12 8 sites

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Recruiting NCT NCT06558188

Combined Anabolic Therapy

Not yet reported Massachusetts General Hospital 50 participants Est. completion 2028-04-01 1 site

Other conditions: Osteoporosis, Postmenopausal, Osteoporosis
View official trial listing →
Recruiting NCT NCT07497503

A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants

Not yet reported Syneos Health 48 participants Est. completion 2026-10-14 1 site

Other conditions: Healthy Volunteers
View official trial listing →
Recruiting NCT NCT07579936

A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens

Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 200 participants Est. completion 2026-11-30 1 site

Other conditions: Postmenopausal Women With Osteoporosis
View official trial listing →
Completed NCT NCT00000400

Alendronate and/or Parathyroid Hormone for Osteoporosis

Not yet reported Massachusetts General Hospital 176 participants Est. completion 2006-06 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00004993

Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis

Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Est. completion 2001-08 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00005006

Parathyroid Hormone (PTH) With Alendronate for Osteoporosis

Not yet reported Helen Hayes Hospital 140 participants Est. completion 2006-12 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00035256

Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis

Not yet reported Eli Lilly and Company 330 participants Est. completion 2005-07 5 sites

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Completed NCT NCT00046137

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Not yet reported Eli Lilly and Company 13 sites

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Completed NCT NCT00051558

Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis

Not yet reported Eli Lilly and Company 428 participants Est. completion 2008-01 15 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00065637

Once Weekly Parathyroid Hormone for Osteoporosis

Not yet reported University of California, San Francisco 50 participants Est. completion 2005-09 1 site Stand-alone

Other conditions: Osteopenia, Osteoporosis
View official trial listing →
Completed NCT NCT00074711

Adding Phosphorus to Osteoporosis Drug Treatment

Not yet reported Creighton University 241 participants Est. completion 2008-06 1 site

Other conditions: Osteoporosis, Osteopenia
View official trial listing →
Completed NCT NCT00079924

Effects of Teriparatide in Postmenopausal Women With Osteoporosis

Not yet reported Eli Lilly and Company 200 participants Est. completion 2007-05 10 sites

Other conditions: Postmenopausal Osteoporosis
View official trial listing →
Completed NCT NCT00086619

Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women

Not yet reported Massachusetts General Hospital 80 participants Est. completion 2009-12 1 site

Other conditions: Postmenopausal Osteoporosis, Osteoporosis
View official trial listing →
Completed NCT NCT00130403

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Not yet reported Sanofi 290 participants Est. completion 2007-03 7 sites

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Completed NCT NCT00131469

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta

Not yet reported Oregon Health and Science University 79 participants Est. completion 2011-01 3 sites

Other conditions: Osteogenesis Imperfecta
View official trial listing →
Completed NCT NCT00190944

Effects of Teriparatide on Distal Radius Fracture Healing

Not yet reported Eli Lilly and Company 105 participants Est. completion 2007-06 7 sites

Other conditions: Colles' Fracture
View official trial listing →
Completed NCT NCT00191321

Teriparatide Use in Hip Replaced Subjects

Not yet reported Eli Lilly and Company 60 participants Est. completion 2005-12 11 sites

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00191425

2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis

Not yet reported Eli Lilly and Company 810 participants Est. completion 2005-11 1 site

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Completed NCT NCT00191802

Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients

Not yet reported Eli Lilly and Company 120 participants Est. completion 2005-10 13 sites

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00191867

Clinical Trial of Teriparatide in Japan

Not yet reported Eli Lilly and Company 160 participants Est. completion 2006-03 6 sites

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00191893

Bone Effects of Teriparatide Following Alendronate

Not yet reported Eli Lilly and Company 66 participants Est. completion 2006-11 2 sites

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00221299

Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use

Not yet reported University of California, Davis 60 participants Est. completion 2009-05 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00239629

Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial

Not yet reported Eli Lilly and Company 73 participants Est. completion 2007-01 11 sites

Other conditions: Postmenopausal Osteoporosis
View official trial listing →
Completed NCT NCT00259298

Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis

Not yet reported Eli Lilly and Company 12 participants Est. completion 2009-07 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00277706

Impact of Parathyroid Hormone (PTH) on Osseous Cavity

Not yet reported University of Michigan 40 participants Est. completion 2009-07 1 site

Other conditions: Bone Loss, Periodontitis
View official trial listing →
Completed NCT NCT00343252

Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis

Not yet reported Eli Lilly and Company 712 participants Est. completion 2010-06 72 sites Stand-alone

Other conditions: Osteoporosis, Postmenopausal, Back Pain, Spinal Fracture
View official trial listing →
Withdrawn NCT NCT00347737

The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL

Not yet reported Leland Graves III, MD Est. completion 2008-05 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00361595

Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women

Not yet reported The Cleveland Clinic 35 participants Est. completion 2008-04 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00365924

A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo

Not yet reported Pfizer 20 participants Est. completion 2008-04 3 sites

Other conditions: Osteoporosis
View official trial listing →
Terminated NCT NCT00393380

Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor

Not yet reported The Emmes Company, LLC 13 participants Est. completion 2012-03 4 sites Stand-alone

Other conditions: Leukemia, Myeloid, Chronic, Anemia, Aplastic, Myelofibrosis, Lymphoma, Hodgkin Disease, Leukemia, Lymphocytic, Chronic, Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute
View official trial listing →
Completed NCT NCT00414973

A Study for Patients With Osteoporosis

Not yet reported Eli Lilly and Company 364 participants Est. completion 2008-07 5 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00433160

Phase 3 Clinical Trial of Teriparatide in Japan

Not yet reported Eli Lilly and Company 207 participants Est. completion 2009-09 16 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00439244

Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis

Not yet reported Novartis 412 participants Est. completion 2009-02 33 sites

Other conditions: Osteoporosis
View official trial listing →
Terminated NCT NCT00446589

The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density

Not yet reported Papageorgiou General Hospital 19 participants 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Terminated NCT NCT00471237

A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

Not yet reported GlaxoSmithKline 564 participants Est. completion 2008-12-26 49 sites

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00473265

Bone Properties in Hypoparathyroidism: Effects of PTH

Not yet reported, Not yet reported John P. Bilezikian 68 participants Est. completion 2014-06 1 site

Other conditions: Hypoparathyroidism
View official trial listing →
Completed NCT NCT00489918

Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis

Not yet reported Zosano Pharma Corporation 165 participants Est. completion 2008-08 Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00503399

Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis

Not yet reported Eli Lilly and Company 92 participants Est. completion 2010-10 13 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00532207

Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Not yet reported Eli Lilly and Company 50 participants Est. completion 2004-12 1 site Stand-alone

Other conditions: Osteoporosis, Post-Menopausal
View official trial listing →
Completed NCT NCT00532545

Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis

Not yet reported Eli Lilly and Company 45 participants Est. completion 2004-04 7 sites Stand-alone

Other conditions: Osteoporosis, Post-Menopausal
View official trial listing →
Completed NCT NCT00535860

Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis

Not yet reported TransPharma Medical 104 participants Est. completion 2009-03 10 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00542425

Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis

Not yet reported Radius Health, Inc. 222 participants Est. completion 2009-06 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00542984

Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis

Not yet reported Eli Lilly and Company 70 participants Est. completion 2004-11 1 site

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Completed NCT NCT00543023

A Study of the Treatment of Postmenopausal Women With Osteoporosis

Not yet reported Eli Lilly and Company 104 participants Est. completion 2004-08 2 sites Stand-alone

Other conditions: Osteoporosis, Post-Menopausal
View official trial listing →
Completed NCT NCT00543218

PTH Comparison in Post Menopausal Women

Not yet reported Eli Lilly and Company 63 participants Est. completion 2004-06 4 sites

Other conditions: Osteoporosis, Post-Menopausal
View official trial listing →
Completed NCT NCT00557310

A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide

Not yet reported Eli Lilly and Company 35 participants Est. completion 2011-05 6 sites Stand-alone

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Completed NCT NCT00577863

Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy

Not yet reported Eli Lilly and Company 200 participants Est. completion 2008-12 18 sites

Other conditions: Osteoporosis
View official trial listing →
Terminated NCT NCT00594906

Use of Teriparatide to Accelerate Fracture Healing

Not yet reported University of Rochester 10 participants Est. completion 2012-07 1 site

Other conditions: Pelvic Fracture
View official trial listing →
Terminated NCT NCT00623974

Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia

Not yet reported M.D. Anderson Cancer Center 7 participants Est. completion 2010-06 1 site Stand-alone

Other conditions: Hypocalcemia
View official trial listing →
Withdrawn NCT NCT00624481

Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD

Not yet reported Nastech Pharmaceutical Company, Inc. 350 participants Est. completion 2009-04 Stand-alone

Other conditions: Osteopenia, Osteoporosis
View official trial listing →
Status unknown NCT NCT00668941

Cyclic Versus Daily Teriparatide on Bone Mass

Not yet reported Helen Hayes Hospital 140 participants Est. completion 2017-11 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00670501

Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Not yet reported Eli Lilly and Company 1637 participants Est. completion 1999-04 17 sites Stand-alone

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Completed NCT NCT00696644

A Study for Teriparatide in Severe Osteoporosis

Eli Lilly and Company 794 participants Est. completion 2011-04 1 site

Other conditions: Osteoporosis, Postmenopausal, Osteoporosis
View official trial listing →
Completed NCT NCT00697463

Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

Not yet reported, Not yet reported Columbia University 22 participants Est. completion 2012-01-03 2 sites Stand-alone

Other conditions: Menopause, Fracture, Osteoporosis
View official trial listing →
Withdrawn NCT NCT00741182

Effect of PTH(1-34) Treatment on Fracture Healing in Vivo

Not yet reported Glostrup University Hospital, Copenhagen Est. completion 2010-09 1 site

Other conditions: Shoulder Fractures, Trochanteric Fractures
View official trial listing →
Completed NCT NCT00754442

Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism

Not yet reported University of Maryland, Baltimore 20 participants Est. completion 2008-08 1 site Stand-alone

Other conditions: Secondary Hyperparathyroidism
View official trial listing →
Completed NCT NCT00759772

The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa

Not yet reported Massachusetts General Hospital 23 participants Est. completion 2016-02-22 1 site

Obstructive sleep apnea Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00761332

Back Pain in Patients With Severe Osteoporosis

Eli Lilly and Company 650 participants Est. completion 2010-12 15 sites

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00826228

Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)

Not yet reported Thomas J. Schnitzer 12 participants Est. completion 2012-12 1 site Stand-alone

Other conditions: Osteoporosis, Bone Loss, Spinal Cord Injury
View official trial listing →
Completed NCT NCT00853723

Comparison Study of PTHrP and PTH to Treat Osteoporosis

Not yet reported University of Pittsburgh 105 participants Est. completion 2012-06 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00887354

A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture

Not yet reported Eli Lilly and Company 224 participants Est. completion 2015-08 28 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00891553

CR9112792, a Follow-up of Study CR9108963

GlaxoSmithKline 171 participants Est. completion 2009-06 3 sites

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00896532

Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density

Not yet reported Amgen 419 participants Est. completion 2016-02-18

Other conditions: Low Bone Mineral Density, Postmenopausal Osteoporosis
View official trial listing →
Completed NCT NCT00926380

Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis

Not yet reported Massachusetts General Hospital 94 participants Est. completion 2016-12 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT00927186

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

Not yet reported Eli Lilly and Company 69 participants Est. completion 2012-04 12 sites Stand-alone

Other conditions: Osteoporosis, Post-menopausal
View official trial listing →
Completed NCT NCT01011556

A Study for the Transdermal Application of Teriparatide

Not yet reported Eli Lilly and Company 233 participants Est. completion 2011-09 18 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT01063504

Teriparatide for Improved Knee Prosthesis Fixation

Not yet reported University Hospital, Linkoeping 60 participants Est. completion 2013-06 1 site

Osteoarthritis
View official trial listing →
Completed NCT NCT01078805

Study of FORTEO Use in Subjects in the Community Setting

Eli Lilly and Company 4167 participants Est. completion 2011-02 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT01105832

Does Teriparatide (rhPTH 1-34) Promote Fracture Healing in Proximal Humeral Fractures?

Not yet reported University Hospital, Linkoeping 40 participants Est. completion 2014-09 2 sites Stand-alone

Other conditions: Humeral Fracture
View official trial listing →
Completed NCT NCT01153425

µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis

Not yet reported University of Pennsylvania 33 participants Est. completion 2012-12 1 site

Other conditions: Osteoporosis, Osteopenia
View official trial listing →
Active, not recruiting NCT NCT01155232

Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis

University Health Network, Toronto 100 participants Est. completion 2028-01 1 site

Other conditions: Osteoporosis
View official trial listing →
Active, not recruiting NCT NCT01155245

Teriparatide (PTH) and Bone Strength in Postmenopausal Women

University Health Network, Toronto 60 participants Est. completion 2028-01 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT01166958

Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?

Not yet reported University of Wisconsin, Madison 26 participants Est. completion 2012-11 1 site

Other conditions: Osteoporosis
View official trial listing →
Terminated NCT NCT01171690

Teriparatide for Postsurgical Hypoparathyroidism

Not yet reported Mayo Clinic 5 participants Est. completion 2013-12 1 site Stand-alone

Other conditions: Hypoparathyroidism Post-surgical
View official trial listing →
Status unknown NCT NCT01173081

The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fractures

Not yet reported Ohio Orthopedic Center of Excellence 38 participants Est. completion 2014-04 1 site Stand-alone

Other conditions: Fractures
View official trial listing →
Completed NCT NCT01224717

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women

Not yet reported Novartis 104 participants 4 sites

Other conditions: Post-menopausal Osteoporosis
View official trial listing →
Completed NCT NCT01225055

Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury

Not yet reported Thomas J. Schnitzer 60 participants Est. completion 2016-08 2 sites Stand-alone

Other conditions: Spinal Cord Injury, Bone Loss, Osteoporosis
View official trial listing →
Completed NCT NCT01250145

A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women

Not yet reported Eli Lilly and Company 251 participants Est. completion 2011-05 5 sites

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Terminated NCT NCT01279187

The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone

Not yet reported University of Michigan 27 participants Est. completion 2015-11 1 site Stand-alone

Other conditions: Implant
View official trial listing →
Completed NCT NCT01292252

Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion

Not yet reported Shane Burch 36 participants Est. completion 2016-12 1 site Stand-alone

Other conditions: Lumbar Spondylosis, Lumbar Spondylolisthesis, Adult Degenerative Lumbar Scoliosis
View official trial listing →
Completed NCT NCT01293292

Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action

Not yet reported Sheffield Teaching Hospitals NHS Foundation Trust 19 participants Est. completion 2015-08 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT01309399

Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur

Not yet reported Health Research, Inc. 40 participants Est. completion 2015-08 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT01321723

Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women

Not yet reported Unigene Laboratories Inc. 97 participants Est. completion 2011-10 4 sites

Other conditions: Postmenopausal Osteoporosis
View official trial listing →
Completed NCT NCT01343004

Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women

Not yet reported Radius Health, Inc. 2463 participants Est. completion 2014-10 28 sites

Other conditions: Osteoporosis, Postmenopausal Osteoporosis
View official trial listing →
Completed NCT NCT01360424

Teriparatide Treatment in Patients With Inherited Osteoporosis

Not yet reported Helsinki University Central Hospital 6 participants Est. completion 2013-11 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT01400516

Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial

Not yet reported Brigham and Women's Hospital 26 participants Est. completion 2016-07-28 3 sites Stand-alone

Other conditions: Rheumatoid Arthritis
View official trial listing →
Completed NCT NCT01430104

A Study of Teriparatide in Japanese Osteoporosis Patients

Not yet reported Eli Lilly and Company 30 participants Est. completion 2011-12 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT01440803

Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women

Not yet reported Elizabeth Shane 41 participants Est. completion 2019-02-01 2 sites

Other conditions: Adult Idiopathic Generalized Osteoporosis
View official trial listing →
Completed NCT NCT01473589

Effect of Teriparatide on Hip Fracture Healing

Not yet reported Eli Lilly and Company 122 participants Est. completion 2013-12 92 sites Stand-alone

Other conditions: Femur Neck Fracture
View official trial listing →
Completed NCT NCT01473602

Second Study of the Effect of Teriparatide on Hip Fracture Healing

Not yet reported Eli Lilly and Company 39 participants Est. completion 2013-11 75 sites Stand-alone

Other conditions: Femur Neck Fracture
View official trial listing →
Completed NCT NCT01535027

Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis

Not yet reported Medical University of Vienna 125 participants Est. completion 2012-12 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT01551602

Clinical Study of AK159 in Healthy Postmenopausal Women

Not yet reported Asahi Kasei Therapeutics Corporation 132 participants Est. completion 2012-10 3 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Status unknown NCT NCT01604057

Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass

Not yet reported Azelon Pharmaceuticals 130 participants Est. completion 2012-07

Other conditions: Osteoporosis, Osteopenia
View official trial listing →
Completed NCT NCT01611571

Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis

Not yet reported Columbia University 31 participants Est. completion 2011-11 1 site

Other conditions: Osteoporosis
View official trial listing →
Terminated NCT NCT01656629

Stem Cell Recruitment in Osteoporosis Therapy

Not yet reported Johns Hopkins University 55 participants Est. completion 2020-08-07 1 site

Other conditions: Low Bone Density
View official trial listing →
Terminated NCT NCT01679080

The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta

Not yet reported University of Aarhus 9 participants Est. completion 2021-06-01 3 sites Stand-alone

Other conditions: Osteogenesis Imperfecta
View official trial listing →
Completed NCT NCT01705587

Fracture (FX) Improvement With Teriparatide: FiX-IT Study

Not yet reported Susan L. Greenspan 13 participants Est. completion 2016-09 1 site Stand-alone

Other conditions: Osteoporosis, Atypical Femoral Fracture
View official trial listing →
Completed NCT NCT01709110

VERtebral Fracture Treatment Comparisons in Osteoporotic Women

Not yet reported Eli Lilly and Company 1366 participants Est. completion 2016-07 103 sites Stand-alone

Other conditions: Postmenopausal Osteoporosis
View official trial listing →
Suspended NCT NCT01734824

Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo

Not yet reported Medical University of Vienna 90 participants Est. completion 2015-09 1 site

Other conditions: Bone Marrow Oedema Syndrome, High Turnover Bone Disease, Quality of Life
View official trial listing →
Completed NCT NCT01750086

Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption

Not yet reported Massachusetts General Hospital 27 participants Est. completion 2014-08 1 site

Other conditions: Postmenopausal Osteoporosis
View official trial listing →
Completed NCT NCT01753856

Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis

Not yet reported Eli Lilly and Company 69 participants Est. completion 2014-06 6 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Status unknown NCT NCT01760798

Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis

Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 20 participants Est. completion 2014-12 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT01796301

An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women

Not yet reported Amgen 436 participants Est. completion 2015-05-14 50 sites

Other conditions: Postmenopausal Osteoporosis
View official trial listing →
Status unknown NCT NCT01801397

A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)

Not yet reported University of Zurich 10 participants Est. completion 2016-12 2 sites

Obstructive sleep apnea
View official trial listing →
Completed NCT NCT01896011

Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures

Not yet reported University Health Network, Toronto 34 participants Est. completion 2022-12 1 site

Other conditions: Non Displaced Atypical Femoral Fractures
View official trial listing →
Status unknown NCT NCT01913834

Nasally and sc Administered Teriparatide in Healthy Volunteers

Not yet reported Nottingham University Hospitals NHS Trust 7 participants Est. completion 2014-08 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT01935479

A Phase I Study of AK159 in Healthy Postmenopausal Women

Not yet reported Asahi Kasei Therapeutics Corporation 170 participants Est. completion 2014-02 3 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Status unknown NCT NCT01945788

Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo

Not yet reported Bio Sidus SA 110 participants Est. completion 2014-11 1 site Stand-alone

Other conditions: Postmenopausal Osteoporosis With Pathological Fracture
View official trial listing →
Status unknown NCT NCT01956461

Effects of Teriparatide Therapy for Japanese

Tomidahama Hospital 500 participants Est. completion 2017-10 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT02023411

Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot

Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 20 participants Est. completion 2018-12 2 sites

Other conditions: Diabetic Neuropathic Arthropathy
View official trial listing →
Completed NCT NCT02025179

12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)

Not yet reported Northwestern University 25 participants Est. completion 2015-08-14 1 site Stand-alone

Other conditions: Spinal Cord Injury, Bone Loss, Osteoporosis
View official trial listing →
Completed NCT NCT02049866

Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP

Not yet reported Elizabeth Shane 33 participants Est. completion 2021-12-23 2 sites

Other conditions: Adult Idiopathic Generalized Osteoporosis
View official trial listing →
Completed NCT NCT02090244

Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?

Not yet reported University Hospital, Linkoeping 34 participants Est. completion 2019-01-01 2 sites Stand-alone

Other conditions: Spinal Stenosis
View official trial listing →
Withdrawn NCT NCT02091492

Teriparatide for Fracture Repair in Humans

Not yet reported Medical University of Vienna Est. completion 2015-09 1 site

Other conditions: Osteoporosis, Age-Related, Humeral Fractures
View official trial listing →
Status unknown NCT NCT02130973

The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab

Not yet reported Health Research, Inc. 60 participants Est. completion 2018-08 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT02152228

A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism

Not yet reported Entera Bio Ltd. 20 participants Est. completion 2015-07 1 site

Other conditions: Hypoparathyroidism
View official trial listing →
Status unknown NCT NCT02156960

Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients

Not yet reported Shinshu University 100 participants Est. completion 2022-11 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Status unknown NCT NCT02166437

Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese

Tomidahama Hospital 500 participants Est. completion 2018-11 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT02176382

Denosumab and Teriparatide Study (DATA-HD and DATA-EX)

Not yet reported Massachusetts General Hospital 76 participants Est. completion 2020-02 1 site

Other conditions: Postmenopausal Osteoporosis
View official trial listing →
Completed NCT NCT02195895

Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide

Not yet reported Northwestern University 17 participants Est. completion 2016-08-05 1 site

Other conditions: Spinal Cord Injury, Bone Loss, Osteoporosis
View official trial listing →
Completed NCT NCT02202603

A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects

Not yet reported Entera Bio Ltd. 42 participants Est. completion 2013-08 1 site Stand-alone

Other conditions: Drug Safety
View official trial listing →
Completed NCT NCT02223416

A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo

Not yet reported Gedeon Richter Plc. 1 site

Other conditions: Healthy
View official trial listing →
Completed NCT NCT02239523

Effectiveness or Orthopedic Intervention in Osteoporosis Management After a Fracture of the Hip With Cost-Benefit Analysis

Not yet reported Shaare Zedek Medical Center 200 participants Est. completion 2019-02-28 1 site

Other conditions: Osteoporotic Fracture
View official trial listing →
Completed NCT NCT02252679

Study of the Diagnostic Value of Stable Calcium Isotope Profiling in Bone and Calcium Disorders

Universitaire Ziekenhuizen KU Leuven 54 participants Est. completion 2018-12 2 sites

Other conditions: Bone Diseases, Osteomalacia, Osteoporosis
View official trial listing →
Status unknown NCT NCT02304887

The Relationship Between the Residual Renal Function and Osteoporosis Treatment

Toshihiko Kono 1000 participants Est. completion 2019-01 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT02416271

The Forteo Alendronate Comparator Trial

Not yet reported Eli Lilly and Company 203 participants Est. completion 2003-05 20 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT02440581

Renal Osteodystrophy: An Individual Management Approach

Not yet reported Hartmut Malluche, MD 141 participants Est. completion 2021-06-30 1 site Stand-alone

Other conditions: Kidney Failure, Chronic
View official trial listing →
Completed NCT NCT02472782

Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication

251 Hellenic Air Force & VA General Hospital 851 participants Est. completion 2018-12-15 1 site

Other conditions: Osteoporosis, Postmenopausal, Osteoporosis, Steroid Induced
View official trial listing →
Completed NCT NCT02478879

A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

Not yet reported Zosano Pharma Corporation 24 participants Est. completion 2015-12 1 site

Other conditions: Postmenopausal Osteoporosis
View official trial listing →
Completed NCT NCT02536898

Norwegian Capture the Fracture Initiative

Not yet reported Oslo University Hospital 94260 participants Est. completion 2020-05 7 sites Stand-alone

Other conditions: Hip Fracture, Vertebral Fracture, Other Low-trauma Fracture
View official trial listing →
Completed NCT NCT02563353

PTH and Vibration in OSteoporosis Study

Not yet reported Odense University Hospital 35 participants Est. completion 2019-11 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT02571140

A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects

Not yet reported Entera Bio Ltd. 30 participants Est. completion 2017-10

Other conditions: Drug Safety and Bioavailability
View official trial listing →
Completed NCT NCT02637180

Secondary Prevention of Osteoporotic Fractures: a Multiple Center Fracture Liaison Service in Greece

Hellenic Society for the Study of Bone Metabolism 397 participants Est. completion 2017-12-07 4 sites

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT02656810

A Comparison Study of PF708 and Forteo in Healthy Subjects

Not yet reported Pfenex, Inc 70 participants Est. completion 2016-07 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT02824718

Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism

Not yet reported Assistance Publique - Hôpitaux de Paris 16 participants Est. completion 2020-05-28 1 site Stand-alone

Other conditions: Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment
View official trial listing →
Status unknown NCT NCT02932501

Medication-related Osteonecrosis of the Jaw (MRONJ) Registry

AO Clinical Investigation and Publishing Documentation 518 participants Est. completion 2024-04 14 sites

Other conditions: Medication-related Osteonecrosis of the Jaw, Bisphosphonate-Associated Osteonecrosis of the Jaw
View official trial listing →
Status unknown NCT NCT02955056

Ankle Fractures Treated With Teriparatide

Not yet reported Nottingham University Hospitals NHS Trust 10 participants Est. completion 2017-10 1 site Stand-alone

Other conditions: Fracture, Ankle
View official trial listing →
Completed NCT NCT02972424

PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial

Not yet reported Hospital for Special Surgery, New York 35 participants Est. completion 2021-07-08 1 site Stand-alone

Other conditions: Osteoporotic Fractures
View official trial listing →
Completed NCT NCT03002428

A Comparison of PF708 and Forteo in Osteoporosis Patients

Not yet reported Pfenex, Inc 181 participants Est. completion 2018-05 26 sites Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT03072147

Teriparatide as a Chondroregenerative Therapy in OA

Not yet reported Christopher Ritchlin 76 participants Est. completion 2022-09-30 1 site

Osteoarthritis Other conditions: Cartilage Degeneration
View official trial listing →
Completed NCT NCT03133195

The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA

Not yet reported King Chulalongkorn Memorial Hospital 50 participants Est. completion 2023-07-01 1 site Stand-alone

Other conditions: Unstable Intertrochanteric Fracture, Pertrochanteric Fracture of Femur, Closed
View official trial listing →
Withdrawn NCT NCT03217513

Knee Osteoarthritis Outcome Measures in Arthritic Patients With Osteoporosis

Edward Fox Est. completion 2024-12-31 1 site

Osteoarthritis Other conditions: Osteoporosis
View official trial listing →
Withdrawn NCT NCT03232476

Effect of Mechanical Loading With PTH on Cortical Bone

Not yet reported Massachusetts General Hospital Est. completion 2019-12

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Completed NCT NCT03472846

MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis

Not yet reported Medical University of Vienna 26 participants Est. completion 2022-09-30 1 site

Other conditions: Postmenopausal Osteoporosis, Diabetes Type 2
View official trial listing →
Active, not recruiting NCT NCT03692143

Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP

Nanfang Hospital, Southern Medical University 90 participants Est. completion 2030-12-01

Other conditions: Osteoporosis, Postmenopausal, Vertebral Fracture, Quality of Life
View official trial listing →
Status unknown NCT NCT03702140

Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy

Not yet reported Shinshu University 90 participants Est. completion 2025-10-08 1 site

Other conditions: Osteoporosis
View official trial listing →
Status unknown NCT NCT03720886

G56W1 in Women With Postmenopausal Osteoporosis

Not yet reported, Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 148 participants Est. completion 2020-08-31 9 sites

Other conditions: Postmenopausal Osteoporosis
View official trial listing →
Completed NCT NCT03735537

Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid

Not yet reported University of Edinburgh 350 participants Est. completion 2025-03-21 23 sites

Other conditions: Osteogenesis Imperfecta
View official trial listing →
Active, not recruiting NCT NCT03770338

Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery

Not yet reported The University of Hong Kong 192 participants Est. completion 2026-06-30 3 sites Stand-alone

Other conditions: Osteoporosis, Fusion of Spine, Lumbar Region
View official trial listing →
Completed NCT NCT03994172

Novel Combination Therapy for Osteoporosis in Men

Not yet reported VA Office of Research and Development 40 participants Est. completion 2025-06-30 1 site Stand-alone

Other conditions: Male Osteoporosis
View official trial listing →
Completed NCT NCT04003467

A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass

Not yet reported Entera Bio Ltd. 161 participants Est. completion 2021-05-11 4 sites

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT04026256

Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration

Not yet reported Massachusetts General Hospital 37 participants Est. completion 2022-04-18 1 site

Other conditions: Postmenopausal Osteoporosis
View official trial listing →
Status unknown NCT NCT04126941

Monocentric Study on the Use of Teriparatide in Children With hypoparathyroïdism

Hospices Civils de Lyon 9 participants Est. completion 2020-12 1 site

Other conditions: Hypoparathyroidism
View official trial listing →
Status unknown NCT NCT04196855

Study of Teriparatide in Stress Fracture Healing

Not yet reported University of East Anglia 136 participants Est. completion 2022-10 1 site Stand-alone

Other conditions: Stress Fracture, Parathyroid Hormone
View official trial listing →
Completed NCT NCT04206618

Circulating Myokine Levels and Bone Metabolism

424 General Military Hospital 220 participants Est. completion 2020-11-10 1 site

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Status unknown NCT NCT04241211

Comparative Study for Incidence of Proximal Junctional Kyphosis Between Parathyroid Hormone and Denosumab Following Adult Spinal Deformity Surgery : A Prospective, Randomized Controlled Trial

Not yet reported Seoul National University Bundang Hospital 64 participants Est. completion 2020-12-31 1 site

Other conditions: Spine Deformity
View official trial listing →
Status unknown NCT NCT04473989

Weekly Use of Teriparatide to Accelerate Healing of Distal Radius Fracture

Not yet reported Peking University Third Hospital 80 participants Est. completion 2024-06-01 Stand-alone

Other conditions: Colles' Fracture
View official trial listing →
Enrolling by invitation NCT NCT04589819

Fracture Recovery for Returning to Duty (Teriparatide STRONG)

Not yet reported University of South Carolina 183 participants Est. completion 2026-12-30 1 site

Other conditions: Stress Fracture of Tibia or Fibula
View official trial listing →
Terminated NCT NCT04669782

Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging

Not yet reported University of Milano Bicocca 99 participants Est. completion 2024-07-04 1 site Stand-alone

Other conditions: Bone Metabolism Disorder, Aging Disorder, Osteoporosis
View official trial listing →
Completed NCT NCT04747392

Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults

Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 64 participants Est. completion 2020-11-11 1 site

Other conditions: Postmenopausal Osteoporosis
View official trial listing →
Completed NCT NCT04750460

Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).

Not yet reported Saint Petersburg State University, Russia 20 participants Est. completion 2022-02-16 1 site Stand-alone

Chronic kidney disease Other conditions: Secondary Hyperparathyroidism, Dialysis, Hypocalcemia, Hypoparathyroidism
View official trial listing →
Completed NCT NCT04879420

Replication of the VERO Osteoporosis Trial in Healthcare Claims Data

Brigham and Women's Hospital 12757 participants Est. completion 2021-06-11 1 site

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT04921124

Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes

Not yet reported Norfolk and Norwich University Hospitals NHS Foundation Trust 30 participants Est. completion 2021-07-09 1 site Stand-alone

Other conditions: Stress Fracture
View official trial listing →
Completed NCT NCT04974723

Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women

Radius Health, Inc. 22054 participants Est. completion 2021-09-30 1 site

Other conditions: Osteoporosis, Postmenopausal
View official trial listing →
Status unknown NCT NCT05018637

Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture

Not yet reported Inbo Han 30 participants Est. completion 2022-12-31 1 site Stand-alone

Other conditions: Vertebral Compression Fracture, Osteoporotic Fractures
View official trial listing →
Active, not recruiting NCT NCT05151484

Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover

Not yet reported Madhumathi Rao 60 participants Est. completion 2027-01-31 1 site

Other conditions: Age-Related Osteoporosis
View official trial listing →
Completed NCT NCT05164614

Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule

Not yet reported RANI Therapeutics 50 participants Est. completion 2022-10-17 1 site

Other conditions: Healthy Volunteers
View official trial listing →
Completed NCT NCT05366621

Post-fracture Medication and Mortality

National Cheng-Kung University Hospital 216155 participants Est. completion 2021-10-31 1 site

Other conditions: Osteoporosis, Osteoporosis Fracture, Drug Therapy, Mortality, Adherence, Medication
View official trial listing →
Status unknown NCT NCT05369013

Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile.

STADA, Spain 188 participants Est. completion 2024-04-14 10 sites

Other conditions: Osteoporosis
View official trial listing →
Completed NCT NCT05965167

Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo

Not yet reported Entera Bio Ltd. 45 participants Est. completion 2026-02-08 1 site

Other conditions: Hypoparathyroidism, Osteoporosis, Fractures, Bone, Other Disease
View official trial listing →
Status unknown NCT NCT06061354

Teriparatide on Maxillary Sinus Floor Osseointegration

Not yet reported Universidad de Valparaiso 42 participants Est. completion 2024-12 1 site Stand-alone

Other conditions: Bone Regeneration
View official trial listing →
Enrolling by invitation NCT NCT06264609

Precision Medicine Approach for Osteoporosis - Follow Up Study

Not yet reported Paul F Netzel 40 participants Est. completion 2029-12-31 1 site Stand-alone

Other conditions: Osteoporosis
View official trial listing →
Not yet recruiting NCT NCT06303284

Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT

Not yet reported, Not yet reported University of Calgary 80 participants Est. completion 2027-06-01 Stand-alone

Other conditions: Ankle Fractures
View official trial listing →
Completed NCT NCT06644040

A Study of TeriQ Patch in Healthy Adult Female Participants

Not yet reported QuadMedicine 24 participants Est. completion 2024-12-30 2 sites

Other conditions: Osteoporosis
View official trial listing →
Active, not recruiting NCT NCT06842758

Relationship Between Thoracic Hyperkyphosis and Fall Risk in Women with Fragility Vertebral Fractures

University of Palermo 40 participants Est. completion 2025-02-28 1 site

Other conditions: Osteoporosis, Hyperkyphosis, Vertebral Body Fracture
View official trial listing →
Not yet recruiting NCT NCT06898060

To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture

Not yet reported Qilu Pharmaceutical Co., Ltd. 282 participants Est. completion 2027-05

Other conditions: Postmenopausal Women With Osteoporosis
View official trial listing →
Not yet recruiting NCT NCT06951776

Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis

Not yet reported Peking University Third Hospital 28 participants Est. completion 2025-12-30 Stand-alone

Other conditions: Circadian Rhythm Disorders, Osteoporosis
View official trial listing →
Completed NCT NCT07028320

To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk

Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 493 participants Est. completion 2024-05-20 1 site

Other conditions: Postmenopausal Women With Osteoporosis
View official trial listing →
Completed NCT NCT07242612

Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis

Not yet reported Khyber Medical University Peshawar 40 participants Est. completion 2026-04-15 1 site Stand-alone

Other conditions: Osteoporosis, Osteoporosis, Postmenopausal
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT00697463

Also known as: Teriparatide, Teriparatide (PTH 1-34)

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.